메뉴 건너뛰기
Current Opinion in Urology
Volumn 21, Issue 3, 2011, Pages 248-251
Intermittent hormonal therapy for prostate cancer
Author keywords

hormonal therapy; intermittent therapy; prostatic cancer
Indexed keywords

BICALUTAMIDE; CYPROTERONE ACETATE; FLUTAMIDE; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;
EID: 79955072326     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328344f3e3     Document Type: Article
Times cited : (3)
References (13)
  • 2
    • 0027369623 scopus 로고
    • Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
    • Denis LJ Murphy GP. Overview of phase III trials on combined androgen treatment in patients with metastatic prostatic cancer. Cancer 1993; 72 (Suppl):3888-3895. (Pubitemid 23361549)
    • (1993) Cancer , vol.72 , Issue.12 SUPPL. , pp. 3888-3895
    • Denis, L.1    Murphy, G.P.2
  • 3
    • 0022007466 scopus 로고
    • Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate
    • DOI 10.1007/BF00261577
    • Vahlensieck W, Wegner G, Lehmann HD, et al. Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate. Urol Res 1985; 13:209-212. (Pubitemid 15226976)
    • (1985) Urological Research , vol.13 , Issue.5 , pp. 209-212
    • Vahlensieck, W.1    Wegner, G.2    Lehmann, H.-D.3
  • 4
    • 0022997273 scopus 로고
    • Intermittent endocrine therapy for advanced prostate cancer
    • DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0. CO;2-N
    • Klotz LH, Herr HW, Morse MJ, Whitmore F Jr. Intermittent endocrine therapy for advanced prostate cancer. Cancer 1986; 58:2546-2550. (Pubitemid 17191621)
    • (1986) Cancer , vol.58 , Issue.11 , pp. 2546-2550
    • Klotz, L.H.1    Herr, H.W.2    Morse, M.J.3    Whitmore Jr., W.F.4
  • 5
    • 0032168442 scopus 로고    scopus 로고
    • Current status of intermittent androgen suppression in the treatment of prostate cancer
    • DOI 10.1016/S0090-4295(98)00251-9, PII S0090429598002519
    • Theyer G, Hamilton G. Current status of intermittent androgen suppression in the intermittent treatment of prostate cancer. Urology 1998; 52:353-359. (Pubitemid 28399897)
    • (1998) Urology , vol.52 , Issue.3 , pp. 353-359
    • Theyer, G.1    Hamilton, G.2
  • 6
    • 0000631145 scopus 로고    scopus 로고
    • A phase II study of intermittent androgen suppression in men with a rising PSA after radiation for localized prostate cancer
    • Bruchovsky N, Klotz LH, Crook JM, et al. A phase II study of intermittent androgen suppression in men with a rising PSA after radiation for localized prostate cancer. J Urol 1998; 159:A1287.
    • (1998) J Urol , vol.159
    • Bruchovsky, N.1    Klotz, L.H.2    Crook, J.M.3
  • 7
    • 0028892410 scopus 로고
    • Intermittent androgen suppression in treatment of prostate cancer: A preliminary report
    • Goldenberg SL, Bruchovsky N, Gleave ME, et al. Intermittent androgen suppression in treatment of prostate cancer: a preliminary report. Urology 1995; 45:839-845.
    • (1995) Urology , vol.45 , pp. 839-845
    • Goldenberg, S.L.1    Bruchovsky, N.2    Gleave, M.E.3
  • 8
    • 0010284551 scopus 로고    scopus 로고
    • Intermittent androgen suppression: Rationale and clinical experience
    • Schroeder F, editor London: Parthenon Publishing
    • Gelave ME, Bruchovsky N, Goldenberg SL, Rennie P. Intermittent androgen suppression: rationale and clinical experience. In: Schroeder F, editor. Recent advances in prostate cancer and BPH. London: Parthenon Publishing; 1997. pp. 109-121.
    • (1997) Recent Advances in Prostate Cancer and BPH , pp. 109-121
    • Gelave, M.E.1    Bruchovsky, N.2    Goldenberg, S.L.3    Rennie, P.4
  • 9
    • 34247111243 scopus 로고    scopus 로고
    • International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: A meta-analysis of 1446 patients
    • DOI 10.1111/j.1464-410X.2007.06770.x
    • Shaw GL, Wilson P, Cuzick J, et al. International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU Int 2007; 99:1056-1065. (Pubitemid 46587917)
    • (2007) BJU International , vol.99 , Issue.5 , pp. 1056-1065
    • Shaw, G.L.1    Wilson, P.2    Cuzick, J.3    Prowse, D.M.4    Goldenberg, S.L.5    Spry, N.A.6    Oliver, T.7
  • 10
    • 70449523110 scopus 로고    scopus 로고
    • Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: A systematic review of the literature
    • Abrahamsson PA. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010; 57:49-59.
    • (2010) Eur Urol , vol.57 , pp. 49-59
    • Abrahamsson, P.A.1
  • 11
    • 65049090443 scopus 로고    scopus 로고
    • Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: Results from a randomised phase III study of the South European Uroncological Group
    • Calais da Silva FE. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase III study of the South European Uroncological Group. Eur Urol 2009; 1269-1277.
    • (2009) Eur Urol , pp. 1269-1277
    • Calais Da Silva, F.E.1
  • 12
    • 79955061715 scopus 로고    scopus 로고
    • Phase III study of intermittent monotherapy vs continuous combined androgen deprivation
    • Calais da Silva F Jr. Phase III study of intermittent monotherapy vs continuous combined androgen deprivation. Abstract 142 25th Anniversary EAU Congress, 2009.
    • (2009) Abstract 142 25th Anniversary EAU Congress
    • Calais Da Silva Jr., F.1
  • 13
    • 36448936367 scopus 로고    scopus 로고
    • EUA guidelines on prostate cancer
    • Heidenreich A, Aus G, Bolla M, et al. EUA guidelines on prostate cancer. Eur Urol 2008; 53:68-80
    • (2008) Eur Urol , vol.53 , pp. 68-80
    • Heidenreich, A.1    Aus, G.2    Bolla, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.